Unrestricted Siemens Healthcare Diagnostics Inc., 2017
|
|
|
- Valerie Elliott
- 5 years ago
- Views:
Transcription
1 Unrestricted Siemens Healthcare Diagnostics Inc., 2017
2
3
4 Underlying socioeconomic, cultural, political, and environmental determinants Common modifiable risk factors Unhealthy diet Physical inactivity Tobacco use Intermediate risk factors Elevated blood pressure Elevated blood glucose Main chronic diseases Heart disease Stroke Cancer Globalization Urbanization Aging population Nonmodifiable risk factors Age Heredity Abnormal blood lipids Overweight/ obesity Chronic respiratory diseases Diabetes
5
6
7 5%
8
9
10
11
12 The outcomes obtained by the Siemens customer described here were realized in the customer s unique setting. Since there is no typical laboratory, and many variables exist, there can be no guarantee that others will achieve the same results. HOOD Page 12 Unrestricted Siemens Healthcare, 2016 All rights reserved.
13
14
15 Source: Crocker, et al. Am J Clin Pathol. 2014;142: The outcomes achieved by Siemens Healthineers customers described herein were achieved in each customers unique setting. Since there is no typical hospital and many variables exist (e.g., hospital size, case mix, level of IT options) there can be no guarantee that others will achieve the same result.
16
17 The outcomes obtained by the Siemens customer described here were realized in the customer s unique setting. Since there is no typical laboratory, and many variables exist, there can be no guarantee that others will achieve the same results.
18 Nuestra Clinica Del Valle (NCDV) Rio Grande, TX REPUTATION CLINICAL Challenge: Reach high risk and underserved population. Deliver education on diabetes and complications prevention. Have results available during visit to impact follow-up. Outcome and Benefits: A flea market testing center offers HbA1c and Albumin-to-Creatinine Ratio (ACR) testing to identify pre-diabetes*, diabetes and kidney disease to encourage steps for follow-up care. DCA Vantage HbA1c test identified that 45% needed follow up care. 50% of persons that went to healthcare center showed a reduction in %HbA1c of ~5.0% over 11 months % 54.60% 20.20% Hemoglobin A1c (HbA1c) N = 498 HbA1c >= 6.5%* HbA1c %* HbA1c <= 5.4% * Referred for follow-up care. *DCA HbA1c test kit (an aid to diagnose diabetes and identify patients at risk for developing diabetes) is not available for sale in the U.S. Product availability varies by country. The outcomes obtained by the Siemens customer described here were realized in the customer s unique setting. Since there is no typical laboratory, and many variables exist, there can be no guarantee that others will achieve the same results.
19 Nuestra Clinica Del Valle (NCDV) Rio Grande, TX Through our pilot 1 with a simple CLIA-waived urine test, we identified 25% of diabetics at high risk of developing nephropathy in our community location, the flea market. 7.4% had severely increased albuminuria (ACR >300 mg/g) and needed immediate medical follow-up. Early identification and treatment has the potential to avoid emergency hemodialysis which can cost more than $250,000 per year 2. Dr. Brian Wickwire Internal Medicine, Ph.D. Biochemistry Normal UACR is defined as <30 mg/g Cr, and increased urinary albumin excretion is defined as > or = 30 mg/g Cr. Beca use of variability in urinary albumin excretion, two of three specimens of UACR collected within a 3- to 6-month period should be abnormal before considering a patient to have albuminuria. Sources: 1. POD2ER: Prevention and Organization against Diabetes Dialysis with Education and Resources: Murtuza, Mohammed M., et al. Poster. 2. Am Kidney Dis 55: The outcomes obtained by the Siemens customer described here were realized in the customer s unique setting. Since there is no typical laboratory, and many variables exist, there can be no guarantee that others will achieve the same results. Profile: Nuestra Clinica Del Valle (NCDV) is a community-health center with 11 clinics in 2 counties serving 30,000 patients (7,000 diabetics). Headquarters reside in San Juan, Texas. Technology: DCA Vantage Analyzer CLINITEK Status + Analyzer CLINITEK Microalbumin 2 Reagent Strips CLINICAL REPUTATION
20 Nuestra Clinica Del Valle Del Valle (NCDV) (NCDV) Rio Grande, Texas, U.S. Rio Grande, TX Challenge: Reach high risk and underserved population at risk of diabetes progressing to severe kidney disease. Deliver education on diabetes and kidney disease prevention. Have results available during visit to impact follow-up. Outcome and Benefits: A flea market testing center offers Albumin-to-Creatinine Ratio (ACR) testing to patients with HbA1c levels above 6.5% for follow-up. Pilot testing identified 25% of patients at high risk of developing diabetic neuropathy. CLINITEK Microalbumin 2 urine strip identified that 7.4% needed follow up for severe diabetic nephropathy. The outcomes obtained by the Siemens customer described here were realized in the customer s unique setting. Since there is no typical laboratory, and many variables exist, there can be no guarantee that others will achieve the same results. Hemoglobin A1c (HbA1c) 54.60% 24.80% 20.20% Albumin-to-Creatinine Ratio (ACR) 58.33% 34.26% HbA1c >= 6.5% HbA1c % HbA1c <= 5.4% N = % CLINICAL N = 108 REPUTATION ACR >300 mg/g ACR mg/g ACR <30 mg/g Normal UACR is defined as <30 mg/g Cr, and increased urinary albumin excretion is defined as > or = 30 mg/g Cr. Because of variability in urinary albumin excretion, two of three specimens of UACR collected within a 3- to 6-month period should be a bnormal before considering a patient to ha ve a lbuminuria.
21
22 DCA Vantage CLINITEK Family Xprecia Stride DIABETES/KIDNEY DISEASE HbA1c and ACR 1 POC HbA1c testing offers benefits for patients who experience barriers to traveling to physician sites for repeated follow-ups visits 1 Immediate feedback of HbA1c levels improves glycemic control in type 1 and type 2 diabetic patients 2 Improve 3 out of 4 HEDIS measures to assess the quality of diabetes management KIDNEY DISEASE/HYPERTENSION ACR, PCR, and Other Key UA Tests Early screening can prevent or delay the progression of kidney disease 3 POC UTI screening outside of hospitals can reduce penalties from hospital re-admissions due to UTI Early screening to detect conditions causing and/or exacerbating high blood pressure can help evaluate the risk of cardiovascular disease STROKE/CVD/ANTICOAGULATION PT/INR A systematic approach to anticoagulation management, focused at the point of care, can increase the time patients are in range and reduce the risk of adverse events 4 Adopting POC PT/INR monitoring lowers costs for managing patients on oral warfarin therapy, increase overall revenue, and improve patient satisfaction 4 Sources: 1) Khunti K, Stone MA, Burden AC, et al. Br J Gen Pract ) Cagliero E, Levina EV, Nathan DM.. Diabetes Care ) Bo Feldt-Rasmussen. Diabetes Voice, ) Tim Huston. Medical Laboratory Observer, 2009
23 Dozens of sites, hundreds of Siemens devices and thousands of operators all controlled with the RAPIDComm Data Management System. Seamlessly transmit data from analyzers to EMR with RELAYMED a subscription-based cloud solution.* Open data-management middleware solution, POCcelerator connects devices from multiple manufacturers. * Designed to connect physician offices with other EHR systems, including Epic, Allscripts, eclinicalworks, NEXTGEN, GE Healthcare, Centricity, Greenway Health, and Athena Health
24 Actionable Results in Minutes Error-free Data Capture Lab-quality Results Cutting-edge Technology World-class Technical Support and Education
25
26
Siemens Healthcare Diagnostics
Siemens Healthcare Diagnostics A Global Industry Leader 3.7bn in sales More than 14,500 employees Serving 30,000 customers in more than 120 countries Approximately 244,000 instruments installed R&D spending
EHR Usage Among PAs. Trends and implications for PAs. April 2019 A Report from the 2018 AAPA PA Practice Survey
EHR Usage Among PAs Trends and implications for PAs April 2019 A Report from the 2018 AAPA PA Practice Survey Contents Methodology... 2 Measures... 2 Notes about the Data... 2 Executive Summary... 3 Data
Diabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153
S150 KEEP 2009 Analytical Methods American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S151 The Kidney Early Evaluation program (KEEP) is a free, communitybased health screening
Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for
Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood
A n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
Diabetes Monitoring: Easy as A-1-C An educational webinar sponsored by Siemens Healthcare Diagnostics
Wednesday, January 14th at 1:00 PM EST Diabetes Monitoring: Easy as A-1-C An educational webinar sponsored by Siemens Healthcare Diagnostics Dr. Nancy Haley Senior Clinical Consultant Agenda Introductions
Early Detection of Chronic Kidney Disease (CKD)
Early Detection of Chronic Kidney Disease (CKD) Gregorio T. Obrador, MD, MPH Dean, Faculty of Health Sciences & School of Medicine Universidad Panamericana, Mexico City Adjunct Assistant Professor of Medicine,
Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care
Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
Electronic Health Records and Electronic Practice Management Systems Hot Topics Survey Results
Electronic Health Records and Electronic Practice Management Systems Hot Topics Survey Results 2018, BSM Consulting All Rights Reserved. 2018, BSM Consulting 1 METHODOLOGY In early fall 2018, BSM Consulting
10/25/2018. Welcome TPCA Lead the Way with Advanced Care Management. Introductions
Welcome TPCA Lead the Way with Advanced Care Management Introductions Let s get to know a little about each other! What emr do you use? NextGen, GE Centricity, ecw, Athena, Allscripts, emds, other: How
Diabetes Audit Results, Portland Area, Site-Specific Trends
Site-Specific Trends The following report contains information from your program's annual diabetes audit submission to the Indian Health Service over the past few years. The report was prepared for your
Applying clinical guidelines treating and managing CKD
Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
Sect S io ecn ti 1 o : n Trend 1: Tres nds
Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood
Aina Blood Monitoring System
Aina Blood Monitoring System Analytical Performance Summary The Aina Blood Monitoring System is a high quality and versatile multi-parameter diagnostic platform that is CE-marked and approved for sale
Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia?
Q99: At what plasma glucose level would glycosuria be expected? Q100: What is the cause of polyemia in hyperglycemia? Q101: What is the cause of polydipsia in the hypoglycemia? Q102: What is the effect
Improving Diabetic Testing in the UT Medicine Primary Care Clinic
Clinical Safety & Effectiveness Session # 1 Improving Diabetic Testing in the UT Medicine Primary Care Clinic August 28, 2009 Educating for Quality Improvement & Patient Safety 1 Background Testing HbA
2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process
Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION
>4000 mg/dl (=20000/(500/100)) >615 mmol/l (=20000/(65*0.5))
Supplemental Table 1 Thresholds to define outliers of lab values in screening test for proteinuria Type of screening test Unit Threshold for Outliers References 24 hour urine albumin mg/d >20000 experienced
Colorado EHR Incentive Program By the Numbers
Colorado EHR Incentive Program By the Numbers September 19, 2017 Micah L. Jones Department of Health Care Policy and Financing About the Speaker Micah L. Jones, J.D. Medicaid Health IT Coordinator Program
SIM HIT Assessment. Table 1: Practice Capacity to Support Data Elements
SIM HIT Assessment This interactive document allows the Clinical Health Information Technology Advisors (CHITAs) to work with a SIM practice to institute sustainable quality improvement. The SIM HIT Assessment:
Improving the Accuracy of Hemoglobin A 1c. : Your Help Is Needed
Improving the Accuracy of Hemoglobin A 1c : Your Help Is Needed Kristina Jackson Behan, PhD, MT(ASCP) (Clinical Laboratory Sciences Program, University of West Florida, Pensacola, FL) DOI: 10.1309/RTVTWPYPTPA5YAGU
Managing Progressive Kidney Disease Andrew S. Narva, MD
Managing Progressive Kidney Disease Andrew S. Narva, MD U.S. Department of Health and Human Services National Institute of Health Managing Progressive Kidney Disease Standards of care for patients with
WELCOME! HemoCue Presentation CPOCT San Diego, September 20 th Annika Eriksson Global Application Manager HemoCue AB
WELCOME! HemoCue Presentation CPOCT San Diego, September 20 th 2014 Annika Eriksson Global Application Manager HemoCue AB HemoCue Part of the Danaher Family 2 Pioneers in Point of care Testing When HemoCue
CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College
CKD FOR INTERNISTS Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College INTRODUCTION In 2002, the National Kidney Foundation s Kidney Disease Outcomes Quality Initiative(KDOQI)
Chapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
GLUCOSE MONITORING. How. When
GLUCOSE MONITORING Why Self-monitoring of blood glucose is the best way to see how your body handles food, activity, diabetes medication (pills and/or insulin), stress and illness. You can also see what
Diabetes Complications Recognition and Treatment
Diabetes Complications Recognition and Treatment Edward Shahady MD, FAAFP, ABCL Clinical Professor Family Medicine Medical Director Diabetes Master Clinician Program Diabetes is the most difficult of all
Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions
Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Andrew S Narva, MD Na/onal Kidney Disease Educa/on Program U.S. Department of Health and Human Services National Institute of
Diabetic Nephropathy
Diabetic Nephropathy Outline Introduction of diabetic nephropathy Manifestations of diabetic nephropathy Staging of diabetic nephropathy Microalbuminuria Diagnosis of diabetic nephropathy Treatment of
International Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Role of HbA1c and Microalbumin as an Early Risk Marker of Diabetic Prithvi Bahadur Shah 1,
Clinical Test Report. of DUS10 (Urine Reagent Strips) Effective Date: April DFI Lab. Dong-Ai Hospital Medical Center: Clinical Pathology
Page 1 / 8 APPROVED Clinical Test Report of DUS10 (Urine Reagent Strips) Effective Date: April. 13. 2010 DFI Lab Dong-Ai Hospital Medical Center: Clinical Pathology Page 2 / 8 The evaluation followed Method
Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA
Management of New-Onset Proteinuria in the Ambulatory Care Setting Akinlolu Ojo, MD, PhD, MBA Urine dipstick results Negative Trace between 15 and 30 mg/dl 1+ between 30 and 100 mg/dl 2+ between 100 and
Coding for Care: Using Data Analytics for Risk Adjustment. March 2, 2016 Clive Fields, MD, President, Village Family Practice
Coding for Care: Using Data Analytics for Risk Adjustment March 2, 2016 Clive Fields, MD, President, Village Family Practice Conflict of Interest Clive Fields, MD, has no real or apparent conflicts of
Clinical Practice Guidelines for Diabetes Management
Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can
NorWest Mobile Diabetes and Kidney Screening and Intervention Project. Cindy Peters Primary Care Nurse
NorWest Mobile Diabetes and Kidney Screening and Intervention Project Cindy Peters Primary Care Nurse Interprofessional and Intersectoral partnerships Aims of FINISHED (First Nations Community Based Screening
Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.
Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test
= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE
Managing Diabetes for Improved Cardiovascular Health Jimmi Norris MS, RN, CDE An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906 0123. Step 2: Enter code 2071585#. Step 3:
DECLARATION OF CONFLICT OF INTEREST. none
DECLARATION OF CONFLICT OF INTEREST none Hypertension and Type 2 Diabetes in The Arab Countries M B BDEIR, MD Director, Cardiac Clinics King Abdulaziz Cardiac Centre, National Guard Health Affairs Riyadh,
Tobacco screening and follow-up if positive for tobacco use
1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 5 45 4 35 3 25 2 15 1 5 16 14 12 1 8 6 4 2 1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 1
Healthcare for the Emerging Middle Class
Healthcare for the Emerging Middle Class Type 2 diabetes care design in India May 2014 1 When looking for healthcare opportunities in emerging markets, project teams on the ground are less influenced by
Northern Territory Point-of-Care Testing Program
Northern Territory Point-of-Care Testing Program Brooke Spaeth, NT POCT Program Coordinator Flinders University International Centre for Point-of-Care Testing Dr Rodney Omond, NT POCT Program Clinical
Diabetes Overview. How Food is Digested
Diabetes Overview You are The Teacher, The Coach and the Fan Pathophysiology of Diabetes Complications Know the Numbers Treatment Can Good Control Make a Difference? Can Tight Control Be too Tight? How
Managing Chronic Kidney Disease: Reducing Risk for CKD Progression
Managing Chronic Kidney Disease: Reducing Risk for CKD Progression Arasu Gopinath, MD Clinical Nephrologist, Medical Director, Jordan Landing Dialysis Center Objectives: Identify the most important risks
International Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Diabetic Dyslipidemia Insulin Resistance May Be One of the Causes of Mahendra D. Bikkad, Suresh
Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home
Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home Background Safety net facility serving the community for more than 140 years Employ over 3500 health
Diabetes. Ref HSCW 024
Diabetes Ref HSCW 024 Why is it important? Diabetes is an increasingly common, life-long, progressive but largely preventable health condition affecting children and adults, causing a heavy burden on health
Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
Diabetic Nephropathy. Objectives:
There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:
Project ECHO: Extension for Community Healthcare Outcomes
Project ECHO: Extension for Community Healthcare Outcomes Kathleen Schmeler, MD Department of Gynecologic Oncology Ellen Baker, MD, MPH Melissa Lopez, MS Cancer Prevention and Control Platform No Financial
Diabetes and the Cardiorenal Syndrome
Wednesday, November 11, 2015 Diabetes and the Cardiorenal Syndrome Dr. Nancy Haley Clinical Consultant Answers for life. Topics Covered Overview The Stats Cardiorenal Syndrome Guidelines Case Studies What
Outcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports
Outcomes of diabetes care in England and Wales A summary of findings from the National Diabetes Audit 2015 16: Complications and Mortality reports About this report This report is for people with diabetes
DIABETES AND CHRONIC KIDNEY DISEASE
DIABETES AND CHRONIC KIDNEY DISEASE Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease Outcomes
Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health
Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program
Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
Urban Diabetes Care and Outcomes Audit Report: Aggregate Results from Urban Indian Health Organizations, May 2012
Urban Diabetes Care and Outcomes Audit Report: Aggregate Results from Urban Indian Health Organizations, 2007-2011 Urban Indian Health Institute A Division of the Seattle Indian Health Board May 2012 Urban
INSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY
INTENDED USE INSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY INSTANT-VIEW H. pylori Rapid Test is a rapid qualitative immunoassay
Urinary albumin creatinine ratio (ACR) A comparative study on two different instruments
Original Research Article Urinary albumin creatinine ratio (ACR) A comparative study on two different instruments Luca Van Rooy 1, Vasudha K C 2*, Vanitha Gowda M N 3, Radhika K 4, Leen Puimege 5 1 Undergraduate
A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy
A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy El-Orabi HA 1, Halawa MR 1, Abd El-Salam MM 1, Eliewa TF 2 and Sherif NSE 1 Internal Medicine and Endocrinology
Supplementary Online Content
Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure
Table of Contents. Page 2 of 20
Page 1 of 20 Table of Contents Table of Contents... 2 NMHCTOD Participants... 3 Introduction... 4 Methodology... 5 Types of Data Available... 5 Diabetes in New Mexico... 7 HEDIS Quality Indicators for
Better Health Partnership
Link Link Building Population Health at Better Health Partnership Making an impact on the Health of Northeast Ohio Thomas E. Love, Ph.D. Chief Data Scientist, Better Health Partnership Professor of Medicine,
COMMUNITY HEALTH NEEDS ASSESSMENT IMPLEMENTATION STRATEGY
2016 COMMUNITY HEALTH NEEDS ASSESSMENT IMPLEMENTATION STRATEGY Table of Contents Introduction... 2 Executive summary... 2 University Care System s mission, vision, and values... 2 Description of the health
www.usrds.org www.usrds.org 1 1,749 + (2,032) 1,563 to Study of Micro Albuminuria and Other Parameters in NIDDM Individuals
IOSR Journal of Dental and Medical Sciences (IOSRJDMS) eissn: 22790853, pissn: 22790861.Volume 15, Issue 2 Ver. I (Feb. 2016), PP 1418 www.iosrjournals.org Study of Albuminuria and Other Parameters in
(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD
Kidney Function Tests (KFTs) IACLD CME, Monday, February 20, 2012 Mohammad Reza Bakhtiari, DCLS, PhD Iranian Research Organization for Science & Technology (IROST) Tehran, Iran Composition and Properties
Pre Diabetes Screening in Primary Care
University of San Diego Digital USD Doctor of Nursing Practice Final Manuscripts Theses and Dissertations Spring 5-21-2016 Pre Diabetes Screening in Primary Care Christine Rieger crieger@sandiego.edu Follow
The contractor establishes and maintains a register of patients with AF
Atrial Fibrillation The contractor establishes and maintains a register of patients with AF G5731 Those patients with AF in whom there is a record of CHADS2 score of 1, the % of patients who are currently
Use of Point-of-Care Tests (POCTs) by US Primary Care Physicians
ORIGINAL RESEARCH Use of Point-of-Care Tests (POCTs) by US Primary Care Physicians Augustine J. Sohn, MD, MPH, John M. Hickner, MD, MSc, and Fasika Alem, MPH Objective: Point-of-care testing (POCT) has
Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
DIABETES MEASURES GROUP OVERVIEW
2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)
* * Interpretation
LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final SUGAR ADVANCE ANEL MICROALBUMIN,1ST MORNING/RANDOM URINE (Immunoturbidimetry,Spectrophotometry)
Hip and Knee Osteoarthritis in Patients with Non-Insulin Dependent Diabetes Mellitus
Hip and Knee Osteoarthritis in Patients with Non-Insulin Dependent Diabetes Mellitus Laurie L. Jansky, MS, Zbigniew Gugala, MD, PhD. The University of Texas Medical Branch, Galveston, TX, USA. Disclosures:
Diabetes Mellitus Registry Report
Diabetes Mellitus Registry Report As Required by Texas Health and Safety Code, Section 95.056 December 2018 Table of Contents Introduction... 1 Background and Status... 2 Conclusion... 1 List of Acronyms...
Supplementary Online Content
Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the
Diabetes 101 A Medical Assistant Training Module
Diabetes 101 A Medical Assistant Training Module July 2014 Wendy Stricklin RN, BSN Clinical Quality Consultant Michigan Primary Care Association www.mpca.net Objectives Participant will have a basic understanding
The CARI Guidelines Caring for Australians with Renal Impairment. 4. Monitoring proteinuria in patients with suspected or known renal disease
4. Monitoring proteinuria in patients with suspected or known renal disease Date written: February 2003 Final submission: June 2004 Guidelines No recommendations possible based on Level I or II evidence
guide Point-of-Care Testing Products
[ tech ] guide Point-of-Care Testing Products 1) What is the name of your company s point-of-care (POC) product or product line? Eurotrol Eurotrol Eurotrol CueSee BGEM LVM CueSee Online CueSee VeriSTAT
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus 1 Contents Executive Summary... 3 How to Screen for Diabetic Nephropathy... 4 What to Measure... 4 Frequency
Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
A Comparative Study of Thyroid Function in Patients of Type 2 Diabetes Mellitus without Nephropathy and Type 2 Diabetes Mellitus With Nephropathy.
DOI: 10.21276/aimdr.2017.3.2.ME4 Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 A Comparative Study of Thyroid Function in Patients of Type 2 Diabetes Mellitus without Nephropathy and Type 2 Diabetes
Renal Physicians Association s Kidney Quality Improvement Registry
Renal Physicians Association s Kidney Quality Improvement Registry State of the World Generating RVUs is not enough Providers are incentivized to manage their population of patients Existing tools practice
Prevalence of Chronic Diseases
Prevalence of Chronic Diseases 81 million American adults have one or more types of cardiovascular disease 1 As many as 1 in 3 American adults will have diagnosed diabetes in 2050 if present trends continue
DCCT Diabetes Control & Complications Trial
DCCT Diabetes Control & Complications Trial A. Vinik MD, PhD, FCP, MACP, FACE, Καθηγητής και Αντιπρόεδρος για την Έρευνα, Ιατρική Σχολή Ανατολικής Βιρτζίνια, Κέντρο Ενδοκρινολογικών και Μεταβολικών Νοσημάτων,
Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment
FOR IMMEDIATE RELEASE Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment Electronic health record-based comparative display of pharmaceutical options
CHI Franciscan. Matt Levi Director Virtual Health Services. March 31, 2015
CHI Franciscan Matt Levi Director Virtual Health Services March 31, 2015 Reflection / 2 Agenda Introduction and background Matt Levi Director of Franciscan Health System Virtual Health Katie Farrell Manager
AtheroRegression Clinic (ARC) Protocols
AtheroRegression Clinic (ARC) Protocols Dmitri Vasin, M.D. Drew Garcia, PA C ARC Goals of Therapy Targets are intentionally simplified and reduced to a bare minimum to keep patients and providers on the
REFERENCE CODE GDHCER052 PUBLICAT ION DATE NOVEMBER 2013 DIABETIC NEPHROPATHY - EPIDEMIOLOGY FORECAST TO 2022
REFERENCE CODE GDHCER052 PUBLICAT ION DATE NOVEMBER 2013 DIABETIC NEPHROPATHY - Executive Summary Diabetic nephropathy is one of the microvascular complications of diabetes, along with diabetic neuropathy
Diabetic Nephropathy
Diabetic Nephropathy Objectives: Know what Diabetic Nephropathy means. Know how common is Diabetic nephropathy in Saudi Arabia and to appreciate how bad are this complications. Know the risk factors of
SOME PRACTICAL CASE STUDIES ON THE USE OF A HOME INTERNET GATEWAY FOR REMOTE PATIENT MONITORING & COACHING PETER VAN VOOREN, FIFTHPLAY
SOME PRACTICAL CASE STUDIES ON THE USE OF A HOME INTERNET GATEWAY FOR REMOTE PATIENT MONITORING & COACHING PETER VAN VOOREN, FIFTHPLAY INTRODUCTION SMART HEALTHCARE & HEALTH MONITORING Healthcare challenges
Laboratory Bulletin...
Laboratory Bulletin... Updates and Information from Rex Healthcare and Rex Outreach February 1997 Issue Number 17 Urinary Microalbumin (an ideal test for real managed care) Microalbuminuria is the term
Reversal of Microalbuminuria A Causative Factor of Diabetic Nephropathy is Achieved with ACE Inhibitors than Strict Glycemic Control
ISSN 0976 3333 Available Online at www.ijpba.info International Journal of Pharmaceutical & Biological Archives 2013; 4(5): 923-928 ORIGINAL RESEARCH ARTICLE Reversal of Microalbuminuria A Causative Factor
Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018
Diabetes and Kidney Disease Kris Bentley Renal Nurse practitioner 2018 Aims Develop an understanding of Chronic Kidney Disease Understand how diabetes impacts on your kidneys Be able to recognise the risk
It s Just a Waived Glucose, Isn t It?
It s Just a Waived Glucose, Isn t It? What Is the Next Step? Becky Damiani, MT (ASCP), Senior Inspection Specialist Laboratory Accreditation Program Objectives Understand the CLIA requirements surrounding
Chronic Kidney Disease Management Program in Shahreza, Iran
KIDNEY DISEASES Chronic Kidney Disease Management Program in Shahreza, Iran Hamid Barahimi, 1 Mohammad Aghighi, 1 Katayon Aghayani, 2 Abbas Rahimi Foroushani 1 Original Paper 1 Tehran University of Medical
Identifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population
Identifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population Fakhrudin A. Mohamed, MD; Jason Kushner, MD, MS; Junita Jose (MSY3); Stephanie C. Clerge,
Physician s Compliance with Diabetic Guideline
Physician s Compliance with Diabetic Guideline Fakhriya Mohammed Fakhroo, CABFCM, MBBS* Sumaiya Abdulkarim, CABFCM, MBBCH* Objective: To assess the blood sugar control of type 2 diabetic patients at primary
Correlation of hyperuricemia with microalbuminuria in patients with type 2 diabetes mellitus in relation to glycemic control.
IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB) ISSN: 2455-264X, Volume 3, Issue 4 (Jul. Aug. 2017), PP 37-43 www.iosrjournals.org Correlation of hyperuricemia with microalbuminuria in patients
Impact of ICD 10 conversion on Quality and Performance Measurement February 29, 2016
Impact of ICD 10 conversion on Quality and Performance Measurement February 29, 2016 Mary Barton, MD National Committee for Quality Assurance Jesse James, MD Evolent Health Conflict of Interest Mary Barton,